Precision Neuroscience
Precision Neuroscience Raises $93M in Series C
Precision Neuroscience Raises $93M in Series C
Precision Neuroscience has successfully raised $93M in a Series C at a $500M valuation led by Steadview Capital, Mubadala Capital.
Company Overview
Precision Neuroscience is a HealthTech company headquartered in New York, NY, founded in 2021 with 120+ employees.
Developer of brain-computer interfaces for medical applications
Fundraising Details
- Amount Raised: $93M
- Round Type: Series C
- Valuation: $500M
- Date: 2024-11-05
- Investors: Steadview Capital, Mubadala Capital
About Precision Neuroscience
Developer of brain-computer interfaces for medical applications The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: New York, NY
- Founded: 2021
- Team Size: 120+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Precision Neuroscience's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Precision Neuroscience's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $500M valuation marks an important milestone for Precision Neuroscience, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Precision Neuroscience is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-11-05. For more information about Precision Neuroscience, visit their headquarters at New York, NY.
Company Info
Share
Related Reports
Basecamp Research Raises $140M Series C for AI-Designed Medicines
Basecamp Research raised a $140 million Series C led by S32 to train new EDEN models and advance AI-designed therapeutics toward clinical development.
Ema Raises $77M Series B to Expand Its Enterprise AI Employee Platform
Ema raised a $77 million Series B led by Creaegis, bringing total funding to $140 million as it scales AI agents across enterprise workflows.
Chamelio Raises $26M Series A for AI-Native Legal Operations
Chamelio raised a $26 million Series A led by Entrée Capital to replace legacy contract-management systems with agentic legal operations.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free